Insulin resistance and atherosclerosis.

Area of Science:

• Metabolic Syndrome
• Cardiovascular Disease Pathophysiology
• Endocrinology

Background:

• The global obesity epidemic is increasing type 2 diabetes, cardiovascular morbidity, and mortality.
• Insulin resistance syndrome is identified as a primary cause of susceptibility to type 2 diabetes and cardiovascular disease.
• Insulin resistance disrupts glucose uptake and leads to hyperglycemia, dyslipidemia, and hypertension.

Purpose of the Study:

• To review the metabolic consequences of insulin resistance syndrome.
• To explore the relationship between insulin resistance and atherosclerosis.
• To examine the impact of insulin resistance on vascular cell signaling pathways involved in atherosclerosis.

Main Methods:

• Literature review of metabolic and cardiovascular research.
• Analysis of insulin signaling pathways in metabolic and cardiovascular tissues.
• Examination of the link between insulin resistance and atherosclerotic processes.

Main Results:

• Insulin resistance impairs phosphatidylinositol-3-kinase (PI3K) mediated insulin signaling in metabolic tissues, causing hyperglycemia.
• In cardiovascular tissues, reduced PI3K signaling and sustained mitogen-activated protein kinase (MAPK) signaling contribute to atherosclerosis.
• Insulin resistance syndrome is a significant risk factor for atherosclerosis development and progression.

Conclusions:

• Insulin resistance syndrome is a central mechanism linking obesity to type 2 diabetes and cardiovascular disease.
• Dysregulated insulin signaling in vascular cells plays a critical role in the pathogenesis of atherosclerosis.
• Targeting insulin resistance pathways may offer therapeutic strategies for preventing cardiovascular complications.